Top insights from the Endpoints at ASCO McKesson leadership panel
Advancing Community Oncology Care
Learn how McKesson is supporting providers and biopharma companies as they find the right treatment options for patients living with cancer.
Today, one in two men and one in three women will hear the words, “You have cancer” in their lifetime. It’s why our company is dedicated to advancing the next generation of cancer care. Through our unparalleled oncology platform, we’re helping bring promising new therapies to market, tackling inequities in healthcare by improving access to care, and providing cutting-edge treatments closer to home.
Learn more about how we’re transforming the fight against cancer in the video above.
Related Stories
Enhancing patient access and engagement in clinical trials.
Learn how InspiroGene is helping deliver revolutionary cell and gene therapies to patients in need.
Insights from the 2025 CoverMyMeds Medication Access Report, From Barriers to Bridges
Learn about the crucial role Sarah Cannon Research Institute (SCRI) played in helping a patient overcome prostate cancer.
For two years in a row, McKesson has partnered with customers and industry partners to bring health education and awareness of resources to members of the Navajo community.
Learn more about RxOwnership, McKesson’s strategic consultants who help independent pharmacy owners navigate challenges, optimize operations and achieve financial health.
During the recent STAT @ ASH event in San Diego, panelists explored the role of community oncology in advancing precision medicine for cancer care.
Learn about McKesson’s new Cell and Gene Therapy (CGT) brand, InspiroGene, and the launch of a first-of-its-kind report about the CGT landscape and its future trajectory.
Learn how pharmacists are transforming patient health across settings.